- Full Report (1.66MB PDF)
- 2–Page summary (881k PDF)
- Descargar El Resumen De 2 Páginas (901k PDF)
- Download Adobe Acrobat Reader
Beta-blockers are used by tens of millions of Americans to treat high blood pressure and other heart ailments. They are effective, life-saving medicines with more than 25 years of widespread and generally safe use.
The cost of these drugs varies from less than $10 per month to more than $200, so your choice of medicine could mean a big difference in expense. Our report, which evaluates the effectiveness, safety, and cost of 15 beta-blockers in the treatment of high blood pressure, angina (the chest pain that occurs in people with coronary artery disease), heart attack and heart failure, gives you information that could save you up to $1,000 to $2,000 a year if you take a generic beta-blocker instead of a brand-name one.
- As a second drug for high blood pressure— atenolol, metoprolol tartrate, nadolol, and propranolol
- For angina — atenolol, metoprolol tartrate, nadolol, and propranolol
- After a heart attack— atenolol, metoprolol tartrate, and propranolol
- For mild heart failure — bisoprolol, carvedilol, and metoprolol succinate
- For severe heart failure — carvedilol
All of these medicines are available as low-cost generics. All have been proven to be either as effective or superior to other beta-blockers. Carvedilol has the strongest evidence of increasing survival in people with the most severe forms of heart failure. A new sustained-release, once-daily form of carvedilol called carvedilol phosphate (Coreg CR) is now available. It has the same active ingredient and, taken once a day, is expected to be as effective against severe heart failure as the immediate-release form, when taken twice daily. But Coreg CR is not yet available as a generic and it is substantially more expensive than the original form of carvedilol.
All beta-blockers are effective against high blood pressure. But because people with high blood pressure may respond to the various beta-blockers differently, you may have to try more than one before finding the drug that works best for you. Beta-blockers are considered “second step” treatment after diuretics (widely known as “water pills”) if you only have high blood pressure and no other heart condition. They are best used in combination with other blood pressure medicines in treating high blood pressure.
In contrast, if you have angina, heart failure, or if you have had a heart attack – with or without high blood pressure – our Best Buy beta-blockers may well be a first step treatment for you.
Note: If the price box contains a
, that indicates the dose of that drug is available for a low monthly cost through programs offered by large chain stores. For example, Kroger, Sam's Club, Target, and Walmart offer a month's supply of selected generic drugs for $4 or a three-month supply for $10. Other chain stores, such as Costco, CVS, Kmart, and Walgreens, offer similar programs. Some programs have restrictions or membership fees, so check the details carefully for restrictions and to make sure your drug is covered.
B. "Generic" indicates that this drug is sold by its generic name. For example, in this table, for the first drug listed, acebutolol, is the generic or chemical name and Sectral is the brand name. Both are available and they have the same active ingredient. In column 2, when the word "generic" appears, the price given is for the generic version. Note that the generic will almost always cost much less than the brand-name version.
C. Depending on your health conditions, symptoms and response to the medicine, your doctor may adjust your dose to be either higher or lower than what we've stated in this price chart.
D. Prices reflect nationwide retail average for January 2011, rounded to the nearest dollar. Information derived by Consumer Reports Health Best Buy Drugs from data provided by Wolters Kluwer Pharma Solutions, which is not involved in our analysis or recommendations.
E. "SR" stands for sustained release.
F. "CD" stands for continuous delivery.
- Full Report (1.66MB PDF)
- 2–Page summary (881k PDF)











